Disorders of the breast
Introduction to breast disease
Virtually every woman with a breast lump, breast pain or discharge from the nipple fears she has cancer. The anxiety results from the unknown course of the disease, the threat of mutilation and the fear of dying. This has often prevented women from seeking medical advice, but publicity about self-examination and screening (see Ch. 6) and the potential benefits of early treatment has encouraged earlier presentation.
Rates of referral to breast clinics have increased, reflecting easier access, widespread breast screening and public awareness of breast cancer. Despite the fears of those referred, in the UK less than 15% prove to have cancer. The rest include benign breast conditions and others within the normal range of anatomy and physiology (see Box 45.1).
Symptoms and signs of breast disease
Patients may present with symptoms or signs (see Fig. 45.1). Two-thirds complain of a discrete lump or lumpiness.
Fig. 45.1 Symptoms and signs of breast disease (see also Figs 45.3 and 45.4)
UK NICE guidelines for urgent and non-urgent referral to a specialist are indicated on a pink background
Special points in history taking
A detailed history can provide important clues to the pathology of a breast problem. Age alters the probability of different breast disorders (see Fig. 45.2); in particular, the risk of malignancy rises with age. The duration of symptoms should be established at the outset; cancers are usually slow-growing, whilst cysts can appear rapidly, sometimes almost overnight. Benign conditions such as fibroadenosis and fibroadenoma may present with lumps that fluctuate with the menstrual cycle or have decreased in size since first noticed. They are also more likely to be painful and tender than a malignant lesion.
A previous history of breast conditions, particularly malignancy, cysts or fibrocystic change, can be an indicator of the nature of a current breast problem. The greatest single risk factor for breast cancer is a previous history of the condition, however long ago (1% risk per year) (see Box 45.2). There is some evidence that patients with recurrent benign breast disorders are more liable to cancer.
Examination of the breasts
There are several accepted methods for examining the breasts; one is shown in Figure 45.3. All areas of the breast must be examined, with particular attention to the axillary tail and retro-areolar regions. Breast examination involves six distinct manoeuvres:
Fig. 45.3 Technique of breast examination
Inspection: the breasts should be inspected for asymmetry, skin tethering and dimpling and changes in colour. This should be performed with the patient sitting comfortably, pressing hands on hips (a), lifting arms in the air (b), and pressing hands on top of the head. Palpation: the patient should sit on an examination couch as shown in (c), with the backrest at about 45° and rolled slightly to the contralateral side. The arm on the side to be examined should be elevated and the head rested on the pillow. The effect of these manoeuvres is to spread the breast over a greater area of the chest wall. The flat of the right hand is used to palpate the breast circumferentially by quadrants (d)–(f). The central part of the breast and the axillary tail must also be palpated. If there is a history of nipple discharge, the areola is pressed in different areas (f) to identify the duct from which it emanates and therefore the segment involved. Finally the axillary lymph nodes are palpated as shown in (g) and (h). The left axilla is palpated with the right hand (h) and the right axilla is palpated with the left hand (g). It is important to relax the axillary muscles by supporting the weight of the patient’s arm as shown. The fingers of the examining hand are firmly held in a curve, pressed high into the apex of the axilla against the chest wall and drawn downwards. The hand will then ‘ride over’ any enlarged axillary nodes
• Observation with the patient sitting up
• Observation with the patient raising and lowering her arms
• Systematic palpation of each breast
During inspection, the signs to be looked for are listed in Figure 45.1.
Palpation may be done circumferentially using the flat of one hand, starting at the nipple then moving in progressively larger circles; radially from the nipple outwards like the spokes of a wheel; or by sectors, examining each quadrant in turn. Axillary lymph nodes are palpated whilst the examiner’s other hand supports the patient’s arm (Fig. 45.3g, h). This helps relax the muscles and aids assessment of the nodal groups (medial, lateral, anterior, posterior and apical). Note that clinical assessment of axillary nodes is unreliable, with a 30% false positive and a 30% false negative rate.
Lumps: The differential diagnosis of a discrete breast mass is:
During the examination the patient needs to point out any lump she is worried about. The normal breast has a wide range of textures, from soft through nodular to hard, so the texture of the rest of the breast must be taken into account. When a lump is found, its characteristics should be defined (see Box 45.3), in particular whether it is discrete or dominant or whether it is an area of nodularity or ‘thickening’. If there is a discrete mass, does it appear benign or suspicious for malignancy? (Characteristic signs of cancer are shown in Fig. 45.4.) Note that even for breast specialists, clinical examination has a low sensitivity (i.e. ability to detect real abnormalities) of 65–80%. In one clinical evaluation system, increasing levels of suspicion are graded E1 to E5; an E3 designation may prompt a core biopsy even if radiological findings are not suspicious. Only 3% of breast cancers occur under the age of 30 but a discrete lump in a patient over 65 is a cancer until proved otherwise.
Investigation of breast disorders
Imaging
Features looked for on a mammogram include:
A typical carcinoma appears as a spiculated mass lesion (dense centre with radiating lines) which may have malignant-type fine linear or granular microcalcification (Fig. 45.5). Fine granular microcalcification within a spiculate lesion is virtually pathognomonic of cancer. Tumours as small as 2–3 mm are sometimes detectable radiologically, long before they become palpable.
Benign-type microcalcification is coarse and ‘chunky’ (Fig. 45.6). Fine branching microcalcification is characteristic of ductal carcinoma-in-situ (DCIS). Architectural distortion and asymmetry are subtle radiological signs but should be viewed with suspicion.
Ultrasound has long been used to distinguish solid lesions from cysts and has a specificity of 100% for this. Modern B-mode ultrasound demonstrates breast anatomy in great detail and is complementary to mammography. Benign lesions can be distinguished from malignancy with a sensitivity for cancer of at least 85%. Ultrasound can accurately measure the size of a cancer (Fig. 45.7) and can guide percutaneous needle biopsies and cyst aspiration (Fig. 45.8).
Biopsy
Most palpable and all non-palpable image-detected masses are biopsied under image guidance, as are suspicious areas of calcification. Fine needle aspiration cytology (FNAC) specimens are rarely used for tissue diagnosis now (see Box 45.4). FNAC has a sensitivity of 95% for detecting malignancy but cannot distinguish between in situ and invasive cancers. By contrast, core biopsy has a sensitivity of 98%. The tissue architecture is preserved so that invasion can be confidently diagnosed on histology and tumours can be pathologically graded. After core biopsy patients need to return later for the results as the pathology has to be read after the specimen has been fixed. This has the advantage that any bad news can be broken in a phased manner. If needle biopsy is negative or equivocal, a discrete lump should be completely excised with a wide margin of apparently normal breast tissue and the specimen examined histologically. This procedure, excision biopsy, can also form the first step in controlling local disease.
Breast cancer
Risk factors
Age: Age is the greatest risk factor. Incidence rates rise from about 25, more steeply between 40 and 55, with a slight levelling off until about 70. After that, another fairly steep rise continues into old age (see Fig. 45.2). Breast cancer is the commonest cause of death in women aged between 40 and 50 years.